Biointerface Technologies, Inc.

Madison, WI 53713

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $0.0
First Award Date 04/01/88
Most Recent Award Date 09/01/91

Key Personnel

Last Name Name Awards Contact
Capelli Christopher C Capelli 2
Winget Rodner R Winget 1

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/91 - 02/28/92

Breast cancer is the most common malignancy in women. For cancer diagnosis, the search for concealed metastases is the single most important factor in the treatment decision for all cancer patients. Even though current methods such as NMR have improved the detection of metastasis, the majority of metastases are rarely detected early. Contrast...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/88 - 12/30/88

Topical antibacterial agents are widely used on burn wounds in an often unsuccessful attempt to prevent/treat infection. Applications of these antimicrobial agents requires the removal of the synthetic dressing. This is frequently painful necessitating narcotic analgesia or general anesthesia. There is a need, therefore, for wound dressing tha...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/88 - 09/30/88

Winget Biotechnology is in the business of developing health and food products from algae. The product described in this proposal is eicosapentaenoic acid (EPA), an essential fatty acid with prophylactic applications to cardiovascular and inflammatory diseases. Among its clinical benefits is the inhibition of thrombogenesis. The proposed rese...